Name
a2a2
Label
Angiotensin Type 2 Antagonists (SHHS2)
Description

Participant taking ANGIOTENSIN TYPE 2 ANTAGONISTS within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Angiotensin Type 2 Antagonists (SHHS2) vs SHHS Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 3,444 -
Yes - - 176 -
Unknown - - 460 -
Angiotensin Type 2 Antagonists (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,587 1,857 3,444
Yes 74 102 176
Unknown 200 260 460
Angiotensin Type 2 Antagonists (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,008 232 204 3,444
Yes 154 10 12 176
Unknown 425 14 21 460